João L. Carapinha

Leveraging Bayh-Dole Act March-In Rights to Reduce US Drug Prices

Earlier Surgery Recommended for Heart-Valve Patients: New Study Insights

Overview of NICE’s Elranatamab Managed Access Agreement

HIQA’s Strategic Blueprint for Health Care Excellence: Draft Corporate ...

Rifaximin Use Linked to Daptomycin Resistance: Implications for Antibiotic St...

NICE Rejects Donanemab for NHS Use Due to Cost Concerns